Stockreport

Aquestive Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Aquestive Therapeutics, Inc.  (AQST) 
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.aquestive.com/investor-relations
PDF Planned U.S. launch of Anaphylmâ„¢ in the first quarter of 2026, if approved by the FDA Advanced Anaphylm regulatory activities in Canada and the EUAdded clinical leadersh [Read more]